PVLA
Palvella Therapeutics, Inc
132.50$
-0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -34.9% | -83.5% | +291.9% | -18.1% | +329.9% | -10.0% | -7.2% | -9.2% | -11.0% | +342.9% | -3.9% | |
| – | -34.5% | -83.5% | +291.9% | -18.1% | +329.9% | -10.0% | -7.2% | -9.2% | -11.9% | +346.3% | -3.9% | |
| – | -47.1% | -64.1% | +215.8% | -1.9% | +331.8% | -9.5% | -6.9% | -9.7% | -8.8% | +256.0% | -9.0% | |
| – | -41.2% | -76.3% | +215.8% | -1.9% | +331.8% | -9.5% | -6.9% | -9.7% | -8.8% | +351.6% | -4.3% | |
| – | +477.9% | +20.0% | -35.5% | -81.2% | +165.8% | -15.3% | +0.0% | +12.0% | -100.0% | – | – | |
| – | -58.7% | +6.2% | -49.9% | -33.0% | +502.4% | -6.9% | +8.8% | +8.8% | +11.8% | -0.4% | +16.3% | |
| – | -58.7% | -77.1% | +132.4% | -33.0% | +183.0% | -25.4% | +7.0% | +7.2% | +10.0% | -19.6% | +31.1% | |
| – | – | – | – | – | – | – | – | – | – | +3.5% | +3.8% | |
| – | +19.7% | -69.7% | -5.1% | -17.3% | +472.5% | -3.2% | +2.6% | -23.6% | +32.0% | +18.5% | +24.7% | |
| – | -12.3% | -123.4% | – | -13.0% | +284.8% | -11.2% | -14.0% | -19.0% | -27.7% | +730.2% | -6.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +2.5% | +2.1% | +2.0% | +68.6% | +0.0% | +396.5% | +0.1% | +1.7% | +16.3% | +9.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.